Long-term Remission of Kaposi's Sarcoma Following Foscarnet Treatment in HIV-infected patients
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 26 (6) , 749-752
- https://doi.org/10.3109/00365549409008645
Abstract
Five patients with HIV-associated Kaposi's sarcoma (epidemic KS) were treated with foscarnet 180 mg/kg/day i.v. for 10 days. Four of them suffered from severe immunodeficiency with CD4 cell counts below 30 × 106/l. Three of the patients went into long-term remission of KS. One patient was free of relapse for 12 months and 2 patients are still in remission after an observation period of 13 and 20 months respectively. The results suggest a possible role of foscarnet in the treatment of epidemic KS.Keywords
This publication has 6 references indexed in Scilit:
- Resolution of Kaposi's sarcomaThe Lancet, 1994
- Kaposiʼs sarcoma as a sexually transmissible infection: an analysis of Australian AIDS surveillance dataAIDS, 1993
- Epidemiologic clues to the etiology of Kaposiʼs sarcomaAIDS, 1993
- Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?The Lancet, 1990
- Lack of activity of zidovudine in AIDS-associated Kaposiʼs sarcomaAIDS, 1989
- Zidovudine in Patients with Human Immunodeficiency Virus (HIV) Infection and Kaposi SarcomaAnnals of Internal Medicine, 1989